Evidence map›Paper›PMID 35005421›Full record

ArticleFrontiers in research metrics and analytics2021

From Tokenization to Self-Supervision: Building a High-Performance Information Extraction System for Chemical Reactions in Patents.

Jingqi Wang, Yuankai Ren, Zhi Zhang, Hua Xu, Yaoyun Zhang

Abstract read
In one paragraph

Article in Frontiers in research metrics and analytics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Transformer models in biomedicine.BMC medical informatics and decision making · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jingqi WangMelax Technologies, Inc., Houston, TX, United States.
Yuankai RenSchool of Medicine, Nantong University, Nantong, China.
Zhi ZhangSchool of Medicine, Nantong University, Nantong, China.
Hua XuSchool of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, United States.
Yaoyun ZhangMelax Technologies, Inc., Houston, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical reactions and experimental conditions are fundamental information for chemical research and pharmaceutical applications. However, the latest information of chemical reactions is usually embedded in the free text of patents. The rapidly accumulating chemical patents urge automatic tools based on natural language processing (NLP) techniques for efficient and accurate information extraction. This work describes the participation of the Melax Tech team in the CLEF 2020-ChEMU Task of Chemical Reaction Extraction from Patent. The task consisted of two subtasks: (1) named entity recognition to identify compounds and different semantic roles in the chemical reaction and (2) event extraction to identify event triggers of chemical reaction and their relations with the semantic roles recognized in subtask 1. To build an end-to-end system with high performance, multiple strategies tailored to chemical patents were applied and evaluated, ranging from optimizing the tokenization, pre-training patent language models based on self-supervision, to domain knowledge-based rules. Our hybrid approaches combining different strategies achieved state-of-the-art results in both subtasks, with the top-ranked F1 of 0.957 for entity recognition and the top-ranked F1 of 0.9536 for event extraction, indicating that the proposed approaches are promising.

Indexed as

chemical patentchemical reactionevent extractionnamed entity recognitionrelation extractionself-supervisiontokenization for chemical patent

Identifiers

PMID35005421
PMCPMC8727901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.